MINI FUTURE LONG - ICON Share Price

Certificat

DE000MG2H3A1

Real-time Bid/Ask 01:41:28 06/06/2024 pm IST
1.29 EUR / 1.33 EUR +2.34% Intraday chart for MINI FUTURE LONG - ICON
Current month+3.23%
1 month+12.28%
Date Price Change
06/24/06 1.28 0.00%
05/24/05 1.28 +5.79%
04/24/04 1.21 -1.63%
03/24/03 1.23 -0.81%
31/24/31 1.24 0.00%

Delayed Quote Börse Stuttgart

Last update June 06, 2024 at 01:28 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying ICON PUBLIC LIMITED COMPANY
Issuer Morgan Stanley
WKN MG2H3A
ISINDE000MG2H3A1
Date issued 17/04/2024
Strike 189.5 $
Maturity Unlimited
Parity 100 : 1
Emission price 1.06
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.28
Lowest since issue 0.94
Spread 0.04
Spread %3.01%

Company Profile

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Sector
-
More about the company

Ratings for ICON Public Limited Company

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: ICON Public Limited Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
329.6 USD
Average target price
362.8 USD
Spread / Average Target
+10.07%
Consensus